Isoflurane 999 MG/ML Inhalation Solution [Forane] — RxCUI 542358
RxNorm drug concept · Semantic branded drug
RxCUI 542358
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI542358
Official nameIsoflurane 999 MG/ML Inhalation Solution [Forane]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asForane 99.9 % Inhalation Solution; Forane 999 MG/ML Inhalation Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Isoflurane 999 MG/ML Inhalation Solution [Forane... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Isoflurane 999 MG/ML Inhalation Solution [Forane]
RxCUI 542358 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Isoflurane
6026IN
-
Isoflurane
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Forane
92754BN
-
Forane
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Isoflurane Inhalation Solution
2108461SCDF -
Isoflurane Inhalant Product
1159154SCDG -
Isoflurane Inhalation Solution [Forane]
2108467SBDF -
Forane Inhalant Product
1172620SBDG -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Isoflurane Inhalation Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Isoflurane 999 MG/ML Inhalation Solution
542347SCD -
Isoflurane 999 MG/ML
542346SCDC -
Isoflurane 999 MG/ML [Forane]
542356SBDC
-
Isoflurane 999 MG/ML Inhalation Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Isoflurane 999 MG/ML Inhalation Solution
SCD · 542347 -
Isoflurane 999 MG/ML
SCDC · 542346 -
Isoflurane Inhalation Solution
SCDF · 2108461 -
Isoflurane Inhalant Product
SCDG · 1159154
Brand-Name Concepts
-
Isoflurane 999 MG/ML [Forane]
SBDC · 542356 -
Isoflurane Inhalation Solution [Forane]
SBDF · 2108467 -
Forane Inhalant Product
SBDG · 1172620 -
Forane
BN · 92754
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 542358 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 10019-0360-40 | 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-40) / 100 mL in 1 B... | FORANE | Baxter Healthcare Corporation | 1979-12-18 |
| 10019-0360-60 | 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-60) / 250 mL in 1 B... | FORANE | Baxter Healthcare Corporation | 1979-12-18 |
Observed labelers:
Baxter Healthcare Corporation (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.